Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$1.49B |
| 2 |
Apple
AAPL
|
$1.09B |
| 3 |
MetLife
MET
|
$844M |
| 4 |
Applied Materials
AMAT
|
$520M |
| 5 |
Chevron
CVX
|
$515M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$961M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
$750M |
| 3 |
Gilead Sciences
GILD
|
$658M |
| 4 |
IBM
IBM
|
$546M |
| 5 |
AstraZeneca
AZN
|
$498M |
Sector Composition
| 1 | Healthcare | 22.15% |
| 2 | Financials | 14.22% |
| 3 | Technology | 12.67% |
| 4 | Energy | 11.41% |
| 5 | Industrials | 10.41% |
